Positioning and Usefulness of Biomarkers in Inflammatory Bowel Disease
Open accessThe DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Abstract
Background: Mucosal healing (MH) was proposed to be an ideal treatment goal for patients with inflammatory bowel disease (IBD). Instead of endoscopy to confirm MH, biomarkers are frequently used and have become an indispensable modality for the clinical examination of patients with IBD. Summary: Common biomarkers of IBD include C-reactive protein (CRP), erythrocyte sedimentation rate, antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, leucine-rich α2 glycoprotein, fecal calprotectin (FCP), and the fecal immunochemical test. Biomarkers play five major roles in the management of IBD: (1) diagnosing and distinguishing between IBD and non-IBD or ulcerative colitis and Crohn’s disease; (2) predicting treatment response, especially before administrating biologics; (3) monitoring and grasping endoscopic or histological disease activity; (4) replacing endoscopy for diagnosing MH, including endoscopic and histological remission; and (5) predicting recurrence before disease activity appears through symptoms. Many reports have demonstrated the usefulness of CRP and FCP for those five roles; however, they have limitations for diagnosing MH or predicting treatment response. In general, FCP has better ability in those positions than CRP; additionally, leucine-rich α2 glycoprotein can diagnose endoscopic disease activity better than CRP. The novel biomarker, prostaglandin E-major urinary metabolite, and anti-αvβ6 antibody are expected to be noninvasive and reliable biomarkers; however, more evidence is required for future studies. Oncostatin M and microRNA are also prospects, in addition to other familiar and novel biomarkers. Key Messages: Each biomarker has a useful feature; therefore, we should consider their features and use appropriate biomarkers for the five roles to enable noninvasive and smooth management of IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One of the primary advantages of the AI-aided fusion multimodal approach is the ability to identify and understand specific and interconnected biological alterations, enabling early and improved disease diagnosis and outcome.85”
From Artificial intelligence and endo-histo-omics: new dimensions of precision endoscopy and histology in inflammatory bowel disease (2024) · cites this paper as [85]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcium's Role in Mechanotransduction during Muscle Development
Benavides Damm, T., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,502
Integrins: Versatility, modulation, and signaling in cell adhesion
Hynes, R. O. (1992) · Cell · doi:10.1016/0092-8674(92)90115-s · Cited by 9,859
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32448-0 · Cited by 6,087
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 3,503
Turner, D., Ricciuto, A., Lewis, A., D’Amico, F., Dhaliwal, J., Griffiths, A. M., Bettenworth, D., Sandborn, W. J., Sands, B. E., Reinisch, W., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.12.031 · Cited by 2,911
Magro, F., Gionchetti, P., Eliakim, R., Ardizzone, S., Armuzzi, A., Barreiro-de Acosta, M., Burisch, J., Gecse, K. B., Hart, A. L., Hindryckx, P., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx008 · Cited by 1,910
Peyrin-Biroulet, L., Sandborn, W., Sands, B. E., Reinisch, W., Bemelman, W., Bryant, R. V., D'Haens, G., Dotan, I., Dubinsky, M., Feagan, B., et al. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.233 · Cited by 1,844
Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based Cohort
Frøslie, K. F., Jahnsen, J., Moum, B. A., & Vatn, M. H. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.051 · Cited by 1,121
Laboratory markers in IBD: useful, magic, or unnecessary toys?
Vermeire, S., Van Assche, G., & Rutgeerts, P. (2006) · Gut · doi:10.1136/gut.2005.069476 · Cited by 952
Colombel, J. F., Rutgeerts, P., Reinisch, W., Esser, D., Wang, Y., Lang, Y., Marano, C. W., Strauss, R., Oddens, B. J., Feagan, B. G., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.054 · Cited by 919
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
DʼHaens, G., Ferrante, M., Vermeire, S., Baert, F., Noman, M., Moortgat, L., Geens, P., Iwens, D., Aerden, I., Van Assche, G., et al. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22917 · Cited by 816
Oxford IBD Cohort Investigators, West, N. R., Hegazy, A. N., Owens, B. M. J., Bullers, S. J., Linggi, B., Buonocore, S., Coccia, M., Görtz, D., This, S., et al. (2017) · Nature Medicine · doi:10.1038/nm.4307 · Cited by 811
Regulation of the immune response by prostaglandins
Goodwin, J. S., & Ceuppens, J. (1983) · Journal of Clinical Immunology · doi:10.1007/bf00915791 · Cited by 715
Sands, B. E., Feagan, B. G., Rutgeerts, P., Colombel, J.-F., Sandborn, W. J., Sy, R., D’Haens, G., Ben-Horin, S., Xu, J., Rosario, M., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.05.008 · Cited by 715
van Rheenen, P. F., Van de Vijver, E., & Fidler, V. (2010) · BMJ · doi:10.1136/bmj.c3369 · Cited by 714
Mosli, M. H., Zou, G., Garg, S. K., Feagan, S. G., MacDonald, J. K., Chande, N., Sandborn, W. J., & Feagan, B. G. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.120 · Cited by 690
Crohn's disease management after intestinal resection: a randomised trial
De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, E. O., Gorelik, A., Liew, D., Prideaux, L., Lawrance, I. C., Andrews, J. M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61908-5 · Cited by 619
Solem, C. A., Loftus, E. V., Tremaine, W. J., Harmsen, W. S., Zinsmeister, A. R., & Sandborn, W. J. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000173271.18319.53 · Cited by 587
Quinton, J.-F., Sendid, B., Reumaux, D., Duthilleul, P., Cortot, A., Grandbastien, B., Charrier, G., Targan, S. R., Colombel, J.-F., & Poulain, D. (1998) · Gut · doi:10.1136/gut.42.6.788 · Cited by 575
Schoepfer, A. M., Beglinger, C., Straumann, A., Trummler, M., Vavricka, S. R., Bruegger, L. E., & Seibold, F. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.545 · Cited by 570
Costa, F., Mumolo, M. G., Ceccarelli, L., Bellini, M., Romano, M. R., Sterpi, C., Ricchiuti, A., Marchi, S., & Bottai, M. (2005) · Gut · doi:10.1136/gut.2004.043406 · Cited by 550
Peyrin-Biroulet, L., Reinisch, W., Colombel, J.-F., Mantzaris, G. J., Kornbluth, A., Diamond, R., Rutgeerts, P., Tang, L. K., Cornillie, F. J., & Sandborn, W. J. (2014) · Gut · doi:10.1136/gutjnl-2013-304984 · Cited by 502
Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis
Bitton, A., Peppercorn, M. A., Antonioli, D. A., Niles, J. L., Shah, S., Bousvaros, A., Ransil, B., Wild, G., Cohen, A., Deb Edwardes, M. D., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.20912 · Cited by 490
Breuss, J. M., Gallo, J., DeLisser, H. M., Klimanskaya, I. V., Folkesson, H. G., Pittet, J. F., Nishimura, S. L., Aldape, K., Landers, D. V., Carpenter, W., et al. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.6.2241 · Cited by 487
Sipponen, T., Savilahti, E., Kolho, K.-L., Nuutinen, H., Turunen, U., & Färkkilä, M. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20312 · Cited by 480
A. G. Røseth, P. N. S. (1999) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365529950172835 · Cited by 422
Henriksen, M., Jahnsen, J., Lygren, I., Stray, N., Sauar, J., Vatn, M. H., Moum, B., & and the IBSEN Study Group (2008) · Gut · doi:10.1136/gut.2007.146357 · Cited by 420
Jones, J., Loftus, E. V., Panaccione, R., Chen, L., Peterson, S., Mcconnell, J., Baudhuin, L., Hanson, K., Feagan, B. G., Harmsen, S. W., et al. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.06.010 · Cited by 414
Diagnostic Precision of Fecal Calprotectin for Inflammatory Bowel Disease and Colorectal Malignancy
von Roon, A. C., Karamountzos, L., Purkayastha, S., Reese, G. E., Darzi, A. W., Teare, J. P., Paraskeva, P., & Tekkis, P. P. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01126.x · Cited by 401
Menees, S. B., Powell, C., Kurlander, J., Goel, A., & Chey, W. D. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.6 · Cited by 391
Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease
Ruemmele, F. M., Targan, S. R., Levy, G., Dubinsky, M., Braun, J., & Seidman, E. G. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70252-5 · Cited by 379
Cornillie, F., Hanauer, S. B., Diamond, R. H., Wang, J., Tang, K. L., Xu, Z., Rutgeerts, P., & Vermeire, S. (2014) · Gut · doi:10.1136/gutjnl-2012-304094 · Cited by 374
Shah, S. C., Colombel, J. ‐., Sands, B. E., & Narula, N. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13475 · Cited by 357
Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease.
Main, J., McKenzie, H., Yeaman, G. R., Kerr, M. A., Robson, D., Pennington, C. R., & Parratt, D. (1988) · BMJ · doi:10.1136/bmj.297.6656.1105 · Cited by 331
Schoepfer, A. M., Beglinger, C., Straumann, A., Trummler, M., Renzulli, P., & Seibold, F. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20986 · Cited by 326
SIPPONEN, T., KÄRKKÄINEN, P., SAVILAHTI, E., KOLHO, K. ‐., NUUTINEN, H., TURUNEN, U., & FÄRKKILÄ, M. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03835.x · Cited by 324
Diagnostic Decision: The Erythrocyte Sedimentation Rate
SOX, H. C., & LIANG, M. H. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-4-515 · Cited by 323
Serum levels of C‐reactive protein in Crohn's disease and ulcerative colitis
FAGAN, E. A., DYCK, R. F., MATON, P. N., HODGSON, H. J. F., CHADWICK, V. S., PETRIE, A., & PEPYS, M. B. (1982) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1982.tb02244.x · Cited by 311
Meta-analysis: Fecal Calprotectin for Assessment of Inflammatory Bowel Disease Activity
Lin, J.-F., Chen, J.-M., Zuo, J.-H., Yu, A., Xiao, Z.-J., Deng, F.-H., Nie, B., & Jiang, B. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000057 · Cited by 296
Schoepfer, A. M., Beglinger, C., Straumann, A., Safroneeva, E., Romero, Y., Armstrong, D., Schmidt, C., Trummler, M., Pittet, V., & Vavricka, S. R. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e3182810066 · Cited by 294
Human calprotectin is an iron-sequestering host-defense protein
Nakashige, T. G., Zhang, B., Krebs, C., & Nolan, E. M. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1891 · Cited by 291
Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse
Nataraj, C., Thomas, D. W., Tilley, S. L., Nguyen, M., Mannon, R. B., Koller, B. H., & Coffman, T. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13640 · Cited by 287
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921c1 · Cited by 283
Mao, R., Xiao, Y.-L., Gao, X., Chen, B.-L., He, Y., Yang, L., Hu, P.-J., & Chen, M.-H. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22861 · Cited by 280
Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse
Nataraj, C., Thomas, D. W., Tilley, S. L., Nguyen, M., Mannon, R., Koller, B. H., & Coffman, T. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113640 · Cited by 278
Reese, G. E., Constantinides, V. A., Simillis, C., Darzi, A. W., Orchard, T. R., Fazio, V. W., & Tekkis, P. P. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00840.x · Cited by 267
Turner, D., Mack, D., Leleiko, N., Walters, T. D., Uusoue, K., Leach, S. T., Day, A. S., Crandall, W., Silverberg, M. S., Markowitz, J., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.02.047 · Cited by 258
Predicting relapse in Crohn’s disease: a biopsychosocial model
Bitton, A., Dobkin, P. L., Edwardes, M. D., Sewitch, M. J., Meddings, J. B., Rawal, S., Cohen, A., Vermeire, S., Dufresne, L., Franchimont, D., et al. (2008) · Gut · doi:10.1136/gut.2007.134817 · Cited by 254
Restricted distribution of integrin beta 6 mRNA in primate epithelial tissues.
Breuss, J. M., Gillett, N., Lu, L., Sheppard, D., & Pytela, R. (1993) · Journal of Histochemistry & Cytochemistry · doi:10.1177/41.10.8245410 · Cited by 237
Sipponen, T., Savilahti, E., Kärkkäinen, P., Kolho, K.-L., Nuutinen, H., Turunen, U., & Färkkilä, M. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20490 · Cited by 236
Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis
Serada, S., Fujimoto, M., Terabe, F., Iijima, H., Shinzaki, S., Matsuzaki, S., Ohkawara, T., Nezu, R., Nakajima, S., Kobayashi, T., et al. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22936 · Cited by 228
Taylor, K. D., Yang, H., Landers, C. J., Rotter, J. I., Targan, S. R., Plevy, S. E., & Barry, M. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.23966 · Cited by 222
Serada, S., Fujimoto, M., Ogata, A., Terabe, F., Hirano, T., Iijima, H., Shinzaki, S., Nishikawa, T., Ohkawara, T., Iwahori, K., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.118919 · Cited by 211
C-reactive protein and the acute phase response.
Ballou, S. P., & Kushner, I. (1992) · PubMed · Cited by 206
Erythrocyte sedimentation rate. From folklore to facts
Bedell, S. E., & Bush, B. T. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90224-4 · Cited by 203
Predictors of early response to infliximab in patients with ulcerative colitis
Ferrante, M., Vermeire, S., Katsanos, K. H., Noman, M., Van Assche, G., Schnitzler, F., Arijs, I., De Hertogh, G., Hoffman, I., Geboes, K., et al. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20054 · Cited by 192
Mitsuyama, K., Toyonaga, A., Sasaki, E., Ishida, O., Ikeda, H., Tsuruta, O., Harada, K., Tateishi, H., Nishiyama, T., & Tanikawa, K. (1995) · Gut · doi:10.1136/gut.36.1.45 · Cited by 186
MicroRNA signatures differentiate Crohn’s disease from ulcerative colitis
Schaefer, J. S., Attumi, T., Opekun, A. R., Abraham, B., Hou, J., Shelby, H., Graham, D. Y., Streckfus, C., & Klein, J. R. (2015) · BMC Immunology · doi:10.1186/s12865-015-0069-0 · Cited by 180
Reinisch, W., Wang, Y., Oddens, B. J., & Link, R. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04987.x · Cited by 179
Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis
Shinzaki, S., Matsuoka, K., Iijima, H., Mizuno, S., Serada, S., Fujimoto, M., Arai, N., Koyama, N., Morii, E., Watanabe, M., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw132 · Cited by 159
Antibody markers in the diagnosis of inflammatory bowel disease
Mitsuyama, K. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i3.1304 · Cited by 155
Heida, A., Park, K. T., & van Rheenen, P. F. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001082 · Cited by 150
Identification of an Anti–Integrin αvβ6 Autoantibody in Patients With Ulcerative Colitis
Kuwada, T., Shiokawa, M., Kodama, Y., Ota, S., Kakiuchi, N., Nannya, Y., Yamazaki, H., Yoshida, H., Nakamura, T., Matsumoto, S., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.02.019 · Cited by 145
Esters, N., Vermeire, S., Joossens, S. B. A., Noman, M., Louis, E., Bélaïche, J., Vos, M. D., Gossum, A. M. V., Pescatore, P., Fiasse, R., et al. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05689.x · Cited by 142
Vos, M. D., Dewit, O., D’Haens, G., Baert, F., Fontaine, F., Vermeire, S., Franchimont, D. P., Moreels, T. G., Staessen, D., Terriere, L., et al. (2011) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2011.11.002 · Cited by 141
Boschetti, G., Laidet, M., Moussata, D., Stéfanescu, C., Roblin, X., Phelip, G., Cotte, E., Passot, G., François, Y., Drai, J., et al. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.30 · Cited by 136
Red Cell Distribution Width for Assessment of Activity of Inflammatory Bowel Disease
Çakal, B., Aköz, A. G., Üstündağ, Y., Yalinkilic, M., Ülker, A., & Ankaralı, H. Ç. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0436-2 · Cited by 134
Denis, M.-A., Reenaers, C., Fontaine, F., Bélaïche, J., & Louis, E. J. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20178 · Cited by 134
Role of endoscopy, cross-sectional imaging and biomarkers in Crohn's disease monitoring
Benitez, J.-M., Meuwis, M., Reenaers, C., Kemseke, C. V., Meunier, P., & Louis, E. J. (2013) · Gut · doi:10.1136/gutjnl-2012-303957 · Cited by 132
Charity begins at home: non-coding RNA functions in DNA repair
Chowdhury, D., Choi, Y. E., & Brault, M. E. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3523 · Cited by 131
Laboratory Tests in the Diagnosis and Follow-Up of Pediatric Rheumatic Diseases: An Update
Breda, L., Nozzi, M., Sanctis, S. D., & Chiarelli, F. (2009) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.12.001 · Cited by 131
Poullis, A. P., Zar, S., Sundaram, K. K., Moodie, S. J., Risley, P., Theodossi, A., & Mendall, M. A. (2002) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200204000-00013 · Cited by 122
Prostaglandin E2 and SOCS1 have a role in intestinal immune tolerance
Chinen, T., Komai, K., Muto, G., Morita, R., Inoue, N., Yoshida, H., Sekiya, T., Yoshida, R., Nakamura, K., Takayanagi, R., et al. (2011) · Nature Communications · doi:10.1038/ncomms1181 · Cited by 122
A simple biological score for predicting low risk of short-term relapse in Crohnʼs disease
Consigny, Y., Modigliani, R., Colombel, J., Dupas, J., Lémann, M., & Mary, J. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.ibd.0000225334.60990.5b · Cited by 121
Orlando, A., Modesto, I., Castiglione, F., Scala, L., Scimeca, D., Rispo, A., Teresi, S., Mocciaro, F., Criscuoli, V. V., Marrone, C., et al. (2006) · PubMed · Cited by 120
HAUPT, H., & BAUDNER, S. (1977) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1977.358.1.639 · Cited by 119
Takashima, S., Kato, J., Hiraoka, S., Nakarai, A., Takei, D., Inokuchi, T., Sugihara, Y., Takahara, M., Harada, K., Okada, H., et al. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.66 · Cited by 117
C-Reactive protein as an aid in the differentiation of functional and inflammatory bowel disorders
Shine, B. S. F., Berghouse, L., Lennard‐Jones, J. E., & Landon, J. (1985) · Clinica Chimica Acta · doi:10.1016/0009-8981(85)90219-0 · Cited by 116
Evaluation of Mucosal Healing of Ulcerative Colitis by a Quantitative Fecal Immunochemical Test
Nakarai, A., Kato, J., Hiraoka, S., Kuriyama, M., Akita, M., Hirakawa, T., Okada, H., & Yamamoto, K. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.315 · Cited by 106
High C-reactive protein in Crohn's disease patients predicts nonresponse to infliximab treatment
Magro, F., Rodrigues‐Pinto, E., Santos‐Antunes, J., Boas, F. V., Lopes, S., Nunes, A. C. R., Dias, C. C., & Macedo, G. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.07.005 · Cited by 104
Predictors of Endoscopic Inflammation in Patients With Ulcerative Colitis in Clinical Remission
Rosenberg, L., Lawlor, G., Zenlea, T., Goldsmith, J. D., Gifford, A. E., Falchuk, K. R., Wolf, J. L., Cheifetz, A. S., Robson, S. C., & Moss, A. C. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e3182802b0e · Cited by 100
Verstockt, S., Verstockt, B., Machiels, K., Vancamelbeke, M., Ferrante, M., Cleynen, I., Hertogh, G. D., & Vermeire, S. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab032 · Cited by 100
HAUPT, H., & BAUDNER, S. (1977) · PubMed · Cited by 99
Oussalah, A., Chevaux, J.-B., Fay, R., Sandborn, W. J., Bigard, M.-A., & Peyrin-Biroulet, L. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.158 · Cited by 96
Fujimoto, M., Serada, S., Suzuki, K., Nishikawa, A., Ogata, A., Nanki, T., Hattori, K., Kohsaka, H., Miyasaka, N., Takeuchi, T., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39164 · Cited by 93
CRP Correlates with Clinical Score in Ulcerative Colitis but Not in Crohn’s Disease
Rodgers, A. D., & Cummins, A. G. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9691-2 · Cited by 93
Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease
Yasutomi, E., Inokuchi, T., Hiraoka, S., Takei, K., Igawa, S., Yamamoto, S., Ohmori, M., Oka, S., Yamasaki, Y., Kinugasa, H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-90441-x · Cited by 89
Shinzaki, S., Matsuoka, K., Tanaka, H., Takeshima, F., Kato, S., Torisu, T., Ohta, Y., Watanabe, K., Nakamura, S., Yoshimura, N., et al. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-021-01793-0 · Cited by 85
Review article: faecal calprotectin and histologic remission in ulcerative colitis
D’Amico, F., Bonovas, S., Danese, S., & Peyrin‐Biroulet, L. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15662 · Cited by 84
Walsh, A., Kormilitzin, A., Hinds, C., Sexton, V., Brain, O., Keshav, S., Uhlig, H., Geddes, J., Goodwin, G., Peters, M., et al. (2019) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjy184 · Cited by 77
Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults
Krzystek‐Korpacka, M., Kempiński, R., Bromke, M. A., & Neubauer, K. (2020) · Diagnostics · doi:10.3390/diagnostics10060367 · Cited by 76
Arai, Y., Arihiro, S., Matsuura, T., Kato, T., Matsuoka, M., Saruta, M., Mitsunaga, M., Matsuura, M., Fujiwara, M., Okayasu, I., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000062 · Cited by 72
Self-citationBertani, L., Fornai, M., Fornili, M., Antonioli, L., Benvenuti, L., Tapete, G., Svizzero, G. B., Ceccarelli, L., Mumolo, M. G., Baglietto, L., et al. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15870 · Cited by 70
Severe ulcerative colitis: Prospective study of parameters determining outcome
Kumar, S., Ghoshal, U. C., Aggarwal, R., Saraswat, V. A., & Choudhuri, G. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03486.x · Cited by 69
Morilla, I., Uzzan, M., Laharie, D., Cazals-Hatem, D., Denost, Q., Daniel, F., Belleannee, G., Bouhnik, Y., Wainrib, G., Panis, Y., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.08.068 · Cited by 67
Wijelath, E. S., Carlsen, B., Cole, T., Chen, J., Kothari, S., & Hammond, W. P. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.7.871 · Cited by 63
Yamamoto, M., Takahashi, T., Serada, S., Sugase, T., Tanaka, K., Miyazaki, Y., Makino, T., Kurokawa, Y., Yamasaki, M., Nakajima, K., et al. (2017) · Cancer Science · doi:10.1111/cas.13329 · Cited by 63
Hart, L., Chavannes, M., Kherad, O., Maedler, C., Mourad, N., Marcus, V., Afif, W., Bitton, A., Lakatos, P. L., Brassard, P., et al. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz107 · Cited by 63
miRNA-Based Potential Biomarkers and New Molecular Insights in Ulcerative Colitis
Zhou, J., Jialing, L., Gao, Y., Shen, L., Li, S., & Chen, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.707776 · Cited by 61
Shiraki, N., Yamazoe, T., Zeng, Q., Ohgomori, K., Mochitate, K., Kume, K., & Kume, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024228 · Cited by 60
Dulai, P. S., Peyrin-Biroulet, L., Danese, S., Sands, B. E., Dignass, A., Turner, D., Mantzaris, G., Schölmerich, J., Mary, J.-Y., Reinisch, W., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.06.018 · Cited by 58
Bertani, L., Blandizzi, C., Mumolo, M. G., Ceccarelli, L., Albano, E., Tapete, G., Svizzero, G. B., Zanzi, F., Coppini, F., de Bortoli, N., et al. (2020) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000174 · Cited by 58
Kawashima, K., Ishihara, S., Yuki, T., Fukuba, N., Sonoyama, H., Kazumori, H., Yamashita, N., Tada, Y., Kusunoki, R., Oka, A., et al. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001202 · Cited by 54
Guo, A., Ross, C., Chande, N., Gregor, J. C., Ponich, T. P., Khanna, R., Sey, M. S. L., Beaton, M. D., Yan, B., Kim, R. B., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-05208-9 · Cited by 53
Batra, S. K., Heier, C. R., Lina Diaz-Calderon, L., Tully, C., Fiorillo, A. A., van den Anker, J. N., & Conklin, L. S. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa209 · Cited by 50
Kawamoto, A., Takenaka, K., Hibiya, S., Ohtsuka, K., Okamoto, R., & Watanabe, M. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.06.036 · Cited by 48
Sabery, N., & Bass, D. (2006) · PEDIATRICS · doi:10.1542/peds.2006-1361 · Cited by 47
The Erythrocyte Sedimentation Rate
Lascari, A. D. (1972) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)32786-9 · Cited by 46
Okayasu, I., Ohnishi, H., Sárándi, I., Shojima, J., Komatsu, J., Oritsu, M., Sasabe, M., Nanami, K. O., Matsuura, M., Azumi, J., et al. (2013) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21640 · Cited by 42
Shinozaki, E., Tanabe, K., Akiyoshi, T., Tsuchida, T., Miyazaki, Y., Kojima, N., Igarashi, M., Ueno, M., Suenaga, M., Mizunuma, N., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4252-6 · Cited by 42
Kawamura, T., Yamamura, T., Nakamura, M., Maeda, K., Sawada, T., Ishikawa, E., Iida, T., Mizutani, Y., Ishikawa, T., Kakushima, N., et al. (2022) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izac076 · Cited by 40
Horikiri, T., Hara, H., Saito, N., Araya, J., Takasaka, N., Utsumi, H., Yanagisawa, H., Hashimoto, M., Yoshii, Y., Wakui, H., et al. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.11.017 · Cited by 39
Yoshimura, T., Mitsuyama, K., Sakemi, R., Takedatsu, H., Yoshioka, S., Kuwaki, K., Mori, A., Fukunaga, S., Araki, T., Morita, M., et al. (2021) · Mediators of Inflammation · doi:10.1155/2021/8825374 · Cited by 39
Separate roles of IL ‐6 and oncostatin M in mouse macrophage polarization in vitro and in vivo
Dubey, A., Izakelian, L., Ayaub, E. A., Ho, L., Stephenson, K. B., Wong, S. C., Kwofie, K., Austin, R. C., Botelho, F. M., Ask, K., et al. (2017) · Immunology and Cell Biology · doi:10.1111/imcb.1035 · Cited by 35
Rubin, D. T., Mulani, P. M., Chao, J., Pollack, P. F., Bensimon, A. G., Yu, A. P., & Ghosh, S. K. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21836 · Cited by 34
Hassan, E. A., El‐Rehim, A. S. E. A., Kholef, E. F., & Elsewify, W. A. E. (2020) · Gastroenterology and hepatology from bed to bench. · Cited by 34
Elevated Pretreatment Plasma Oncostatin M Is Associated With Poor Biochemical Response to Infliximab
Minar, P., Lehn, C. N., Tsai, Y.-T., Jackson, K., Rosen, M. J., & Denson, L. A. (2019) · Crohn s & Colitis 360 · doi:10.1093/crocol/otz026 · Cited by 34
Hiraoka, S., Kato, J., Nakarai, A., Takashima, S., Inokuchi, T., Takei, D., Sugihara, Y., Takahara, M., Harada, K., & Okada, H. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw025 · Cited by 32
Measurement of prostaglandin metabolites is useful in diagnosis of small bowel ulcerations
Matsuno, Y., Umeno, J., Esaki, M., Hirakawa, Y., Fuyuno, Y., Okamoto, Y., Hirano, A., Yasukawa, S., Hirai, F., Matsui, T., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i14.1753 · Cited by 32
Surrogate markers of mucosal healing in inflammatory bowel disease: A systematic review
State, M., Negreanu, L. M., Voiosu, T. A., Voiosu, A. M., Balanescu, P. C., & Mateescu, B. R. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i16.1828 · Cited by 32
Long-Term Outcome of Crohn's Disease Following Corticosteroid-Induced Remission
Papi, C., Festa, V., Leandro, G., Moretti, A., Tanga, M., Koch, M., & Capurso, L. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01055.x · Cited by 31
Takedatsu, H., Mitsuyama, K., Fukunaga, S., Yoshioka, S., Yamauchi, R., Mori, A., Yamasaki, H., Kuwaki, K., Sakisaka, H., Sakisaka, S., et al. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14140 · Cited by 31
Alphavbeta6 is required in maintaining the intestinal epithelial barrier function
Yu, Y., Chen, S., Lu, G., Wu, Y., Mo, L., Liu, Z., Zheng, P., Liu, Z., & Yang, P. (2014) · Cell Biology International · doi:10.1002/cbin.10258 · Cited by 29
Iwamoto, F., Matsuoka, K., Motobayashi, M., Takenaka, K., Kuno, T., Tanaka, K., Tsukui, Y., Kobayashi, S., Yoshida, T., Fujii, T., et al. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14310 · Cited by 28
Narula, N., Wong, E. C. L., Dulai, P. S., Marshall, J. K., Colombel, J., & Reinisch, W. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa189 · Cited by 28
Prostaglandin E‐major Urinary Metabolite as a Biomarker for Pediatric Ulcerative Colitis Activity
Hagiwara, S., Okayasu, I., Fujiwara, M., Matsuura, M., Ohnishi, H., Ito, S., Kishimoto, H., Nambu, R., & Kagimoto, S. (2016) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001477 · Cited by 27
Fujiwara, M., Okayasu, I., Oritsu, M., Komatsu, J., Yoshitsugu, M., Katoh, Y., Bandoh, T., Toyoshima, H., Kase, Y., SUGIHARA, K., et al. (2000) · Digestion · doi:10.1159/000007758 · Cited by 25
Luo, J., Wang, Y., Lan, D., Niu, J., Miao, J., Dong, X., Yang, G., Zhang, F., Cao, Y., Wang, K., et al. (2018) · PubMed Central · Cited by 22
Bertani, L., Barberio, B., Fornili, M., Antonioli, L., Zanzi, F., Casadei, C., Benvenuti, L., Facchin, S., D’Antongiovanni, V., Lorenzon, G., et al. (2022) · Digestive and Liver Disease · doi:10.1016/j.dld.2022.03.008 · Cited by 22
Sakurai, T., Akita, Y., Miyashita, H., Miyazaki, R., Maruyama, Y., Saito, T., Shimada, M., Yamasaki, T., Arihiro, S., Kato, T., et al. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15782 · Cited by 21
Self-citationSterbova, S., Karlsson, T., & Persson, E. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.03.056 · Cited by 19
Omori, T., Sasaki, Y., Koroku, M., Murasugi, S., Yonezawa, M., Nakamura, S., & Tokushige, K. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092494 · Cited by 18
Ishida, N., Sugiura, K., Miyazu, T., Tamura, S., Suzuki, S., Tani, S., Yamade, M., Iwaizumi, M., Hamaya, Y., Osawa, S., et al. (2020) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000289 · Cited by 17
Simplified immunoassays of prostaglandin E main metabolite in human urine.
Inagawa, T., Imaki, K., Masuda, H., Morikawa, Y., Hirata, F., & TSUBOSHIMA, M. (1983) · PubMed · Cited by 15
Ishida, N., Tamura, S., Miyazu, T., Tani, S., Yamade, M., Iwaizumi, M., Hamaya, Y., Osawa, S., Furuta, T., & Sugimoto, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-95761-6 · Cited by 15
Shimizu, H., Ebana, R., Kudo, T., Sato, T., Hara, T., Hosoi, K., Usami, M., Yoshida, M., Takeuchi, I., Nakase, H., et al. (2022) · Journal of Gastroenterology · doi:10.1007/s00535-022-01856-w · Cited by 15
Lin, S., Chanchlani, N., Invergo, B. M., Anderson, M., Guay, H., Reppell, M., Butler, J. W., Goodhand, J., Ahmad, T., & Kennedy, N. A. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz203.067 · Cited by 3
Cited by
Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments
Wangchuk, P., Yeshi, K., & Loukas, A. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.08.003 · Cited by 333
Díez-Martín, E., Hernández-Suárez, L., Muñoz‐Villafranca, C., Martin–Souto, L., Astigarraga, E., Ramirez‐Garcia, A., & Barreda‐Gómez, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137062 · Cited by 133
“Additionally, calprotectin found in fecal samples can provide a measure of specific intestinal inflammation, whereas that obtained from other fluids offers a more general measure of body inflammation [223].”
InfluentialBiomarkers in inflammatory bowel disease: a practical guide
Clough, J., Colwill, M., Poullis, A. P., Pollok, R., Patel, K., & Honap, S. (2024) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848241251600 · Cited by 116
“13 For clinicians, there are also further considerations such as availability, turn-around time for testing and robustness of the analytic method used.”
MethodJiang, W. J., Yin, J., Han, M., He, W., Zhao, Y., Hu, J., Wang, M., Wang, S., Xu, J., Deng, C., et al. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s518155 · Cited by 88
“43 Detecting the expression of N4BP3 in the blood from IBD patients and normal populations, analyzing the correlation between the expression of N4BP3 in the blood and IBD, which may provide a new method for the diagnosis of IBD.”
Iacucci, M., Santacroce, G., Zammarchi, I., Maeda, Y., Del Amor, R., Meseguer, P., Kolawole, B. B., Chaudhari, U., Di Sabatino, A., Danese, S., et al. (2024) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(24)00053-0 · Cited by 73
Metadata
- Authors
- Sakurai, T., & Saruta, M.
- Affiliations
- Jikei University School of Medicine (JP)
- Corresponding author
- Sakurai, Toshiyuki
- Venue
- Digestion
- Publisher
- S. Karger AG
- Published
- 2022-11-18
- Volume
- 104
- Issue
- 1
- Pages
- 30-41
- ISSN
- 0012-2823 (ISSN-L)
- 1421-9867
- PMC
- PMC9843547
- OpenAlex
- W4309466247
- Cited by
- 156
- References
- 137
- Citations by year
- 2026: 43 · 2025: 48 · 2024: 42 · 2023: 23
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0/ (vor)
- creativecommons.org/licenses/by-nc/4.0/ (tdm)
- Locations
- Digestion (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- inflammatory bowel disease, biomarkers, mucosal healing, fecal calprotectin, C-reactive protein, LRG1, ASCA, antineutrophil cytoplasmic antibodies, fecal immunochemical test, disease activity monitoring, treatment response prediction, disease recurrence prediction, ulcerative colitis, Crohn's disease, non-invasive diagnosis, oncostatin M, microRNA
- MeSH terms
- C-Reactive Protein, Colitis, Ulcerative, Feces, Glycoproteins, Humans, Leucine, Severity of Illness Index, Inflammatory Bowel Diseases, Biomarkers, Leukocyte L1 Antigen Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.